Position history for BlackRock, Inc.'s holdings in XERIS BIOPHARMA HOLDINGS INC
BlackRock, Inc. holds 12.9M shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $75.1M as of 2026-Q1. The position was increased (+2.4% shares). XERS represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$75.1M
Current Shares
12.9M
Total Value Change
+$38.4M
Total Shares Change
+2.1M
Other major holders of XERS: VANGUARD GROUP INC, D. E. Shaw & Co., Inc.
Increased |
| 12.9M |
+2.4% |
| $75.1M |
| 0.0% |
| $5.94 |
30 |
| 2025-Q4 | Increased | 12.6M | +6.0% | $99.2M | 0.0% | $7.31 | 32 |
| 2025-Q3 | Increased | 11.9M | +3.4% | $97.1M | 0.0% | $8.08 | 31 |
| 2025-Q2 | Increased | 11.5M | +6.9% | $53.9M | 0.0% | $4.70 | 31 |
| 2025-Q1 | Decreased | 10.8M | -0.3% | $59.3M | 0.0% | $5.58 | 0 |
| 2024-Q4 | New | 10.8M | - | $36.7M | 0.0% | $3.38 | 40 |